Hoyle, Anna
Jabban, Leen
Rivadulla, Adrian R.
Nyírő, Balázs
O’Neill, Eamonn
Metcalfe, Benjamin
Coyle, Damien
Article History
Received: 26 January 2026
Accepted: 29 July 2026
First Online: 25 September 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: Damien Coyle is CEO and shareholder of neurotechnology company, NeuroCONCISE Ltd.